These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 8388405

  • 21. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C, Luna S, Hernández L, Crespo G, Aguayo P, Arteaga-Troncoso G, Parra A.
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1360-5. PubMed ID: 15598674
    [Abstract] [Full Text] [Related]

  • 22. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO, Yarali H, Oguz H, Bayraktar M.
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [Abstract] [Full Text] [Related]

  • 23. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
    Tropeano G, Lucisano A, Liberale I, Barini A, Vuolo IP, Martino G, Menini E, Dell'Acqua S.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
    [Abstract] [Full Text] [Related]

  • 24. Role of androgens in menstrual disorders of nonhirsute and hirsute women, and the effect of glucocorticoid therapy on androgen levels in hirsute hyperandrogenic women.
    Ho Yuen B, Mincey EK.
    Am J Obstet Gynecol; 1983 Jan 15; 145(2):152-7. PubMed ID: 6401396
    [Abstract] [Full Text] [Related]

  • 25. Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome.
    González F, Rote NS, Minium J, Kirwan JP.
    J Clin Endocrinol Metab; 2006 Apr 15; 91(4):1508-12. PubMed ID: 16464947
    [Abstract] [Full Text] [Related]

  • 26. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug 15; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 27. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
    Romualdi D, De Cicco S, Tagliaferri V, Proto C, Lanzone A, Guido M.
    J Clin Endocrinol Metab; 2011 May 15; 96(5):E821-4. PubMed ID: 21307134
    [Abstract] [Full Text] [Related]

  • 28. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C.
    Clin Endocrinol (Oxf); 2004 Dec 15; 61(6):738-46. PubMed ID: 15579189
    [Abstract] [Full Text] [Related]

  • 29. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, Votsi E, Diamanti-Kandarakis E.
    Fertil Steril; 2006 Jun 15; 85(6):1778-83. PubMed ID: 16650418
    [Abstract] [Full Text] [Related]

  • 30. Insulin sensitivity in women with polycystic ovary syndrome.
    Vrbíková J, Cibula D, Dvoráková K, Stanická S, Sindelka G, Hill M, Fanta M, Vondra K, Skrha J.
    J Clin Endocrinol Metab; 2004 Jun 15; 89(6):2942-5. PubMed ID: 15181081
    [Abstract] [Full Text] [Related]

  • 31. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
    Falcone T, Finegood DT, Fantus IG, Morris D.
    J Clin Endocrinol Metab; 1990 Dec 15; 71(6):1653-7. PubMed ID: 2146285
    [Abstract] [Full Text] [Related]

  • 32. [Insulin resistance in obese and non-obese patients with polycystic ovary syndrome. Possible role in the pathogenesis of the disease].
    Vagiri D, Barletta C, Cioli I, Scavo D.
    Minerva Endocrinol; 1994 Mar 15; 19(1):5-12. PubMed ID: 8035770
    [Abstract] [Full Text] [Related]

  • 33. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels.
    Pagotto U, Gambineri A, Vicennati V, Heiman ML, Tschöp M, Pasquali R.
    J Clin Endocrinol Metab; 2002 Dec 15; 87(12):5625-9. PubMed ID: 12466363
    [Abstract] [Full Text] [Related]

  • 34. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul 15; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 35. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I, Straczkowski M, Nikolajuk A, Adamska A, Karczewska-Kupczewska M, Otziomek E, Wolczynski S, Gorska M.
    Hum Reprod; 2007 Jul 15; 22(7):1824-9. PubMed ID: 17582143
    [Abstract] [Full Text] [Related]

  • 36. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G.
    J Clin Endocrinol Metab; 2011 Mar 15; 96(3):623-31. PubMed ID: 21177795
    [Abstract] [Full Text] [Related]

  • 37. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S, Teede HJ, Moran LJ, Joham AE, Harrison CL, Strauss BJ, Stepto NK.
    Clin Endocrinol (Oxf); 2014 Dec 15; 81(6):899-906. PubMed ID: 25040369
    [Abstract] [Full Text] [Related]

  • 38. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V, Nagamani M.
    J Soc Gynecol Investig; 2005 Feb 15; 12(2):129-34. PubMed ID: 15695109
    [Abstract] [Full Text] [Related]

  • 39. [Probable role of obesity on the adrenal response to acute stimulation with adrenocorticotrophic hormone in eumenorrheic and hirsute, non-eumenorrheic women].
    Villa S, Schutz I, Mainini E, Mazzi C, Mazzi C.
    Minerva Endocrinol; 1993 Mar 15; 18(1):13-9. PubMed ID: 8232117
    [Abstract] [Full Text] [Related]

  • 40. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.
    Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen JS.
    J Clin Endocrinol Metab; 2009 Jun 15; 94(6):1973-8. PubMed ID: 19318449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.